BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26481918)

  • 1. Role of propranolol in ulcerated haemangioma of head and neck: a prospective comparative study.
    Tiwari P; Pandey V; Gangopadhyay AN; Sharma SP; Gupta DK
    Oral Maxillofac Surg; 2016 Mar; 20(1):73-7. PubMed ID: 26481918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of factors affecting the therapeutic effect of propranolol for infantile haemangioma of the head and neck.
    Dong JY; Ning JX; Li K; Liu C; Wang XX; Li RH; Yue LL; Huang YY; Liu SH
    Sci Rep; 2017 Mar; 7(1):342. PubMed ID: 28336941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shouldn't Propranolol Be Used to Treat All Haemangiomas?
    Moodley ST; Hudson DA; Adams S; Adams KG
    Aesthetic Plast Surg; 2015 Dec; 39(6):963-7. PubMed ID: 26377820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol for infantile haemangioma: striking effect in the first weeks.
    Katona G; Csákányi Z; Gács E; Szalai Z; Ráth G; Gerlinger I
    Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1746-50. PubMed ID: 22944359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol for treatment of ulcerated infantile hemangiomas.
    Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
    J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
    Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
    J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination of pulsed dye laser and propranolol in the treatment of ulcerated infantile haemangioma].
    Rodríguez-Ruiz M; Tellado MG; del Pozo Losada J
    An Pediatr (Barc); 2016 Feb; 84(2):92-6. PubMed ID: 26002439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids as an adjunct to propranolol for infantile haemangiomas complicated by recalcitrant ulceration.
    Lie E; Püttgen KB
    Br J Dermatol; 2017 Apr; 176(4):1064-1067. PubMed ID: 27479792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.
    Hermans DJ; van Beynum IM; Schultze Kool LJ; van de Kerkhof PC; Wijnen MH; van der Vleuten CJ
    J Am Acad Dermatol; 2011 May; 64(5):833-8. PubMed ID: 21353329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol given orally for proliferating infantile haemangiomas: analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients.
    Yuan WL; Jin ZL; Wei JJ; Liu ZY; Xue L; Wang XK
    Br J Oral Maxillofac Surg; 2013 Oct; 51(7):656-61. PubMed ID: 23291092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of propranolol in infantile haemangioma among Chinese children.
    Chik KK; Luk CK; Chan HB; Tan HY
    Hong Kong Med J; 2010 Oct; 16(5):341-6. PubMed ID: 20889997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.
    Holmes WJ; Mishra A; Gorst C; Liew SH
    J Plast Reconstr Aesthet Surg; 2011 Apr; 64(4):445-51. PubMed ID: 20797926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulcerated nasal infantile haemangioma treated by oral propranolol.
    Al Dosari S; Riad H
    Dermatol Online J; 2013 May; 19(5):18298. PubMed ID: 24011285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of propranolol for treatment of infantile haemangiomas in an outpatient setting.
    Phillips RJ; Penington AJ; Bekhor PS; Crock CM
    J Paediatr Child Health; 2012 Oct; 48(10):902-6. PubMed ID: 22897120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol in the management of periorbital infantile haemangioma.
    Cheng JF; Gole GA; Sullivan TJ
    Clin Exp Ophthalmol; 2010 Aug; 38(6):547-53. PubMed ID: 20553300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
    Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
    Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
    Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective analysis of systemic propranolol for the treatment of complicated infantile haemangiomas.
    Schneider M; Cremer HJ; Ruef P
    Acta Paediatr; 2014 Sep; 103(9):977-83. PubMed ID: 24837972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose propranolol for infantile haemangioma.
    Tan ST; Itinteang T; Leadbitter P
    J Plast Reconstr Aesthet Surg; 2011 Mar; 64(3):292-9. PubMed ID: 20615772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Response to oral propranolol therapy for ulcerated hemangiomas in infancy].
    Michel JL; Patural H
    Arch Pediatr; 2009 Dec; 16(12):1565-8. PubMed ID: 19892536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.